SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015628
Filing Date
2021-11-12
Accepted
2021-11-12 07:00:52
Documents
86
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q casi-20210930x10q.htm   iXBRL 10-Q 1797827
2 EX-31.1 casi-20210930xex31d1.htm EX-31.1 12956
3 EX-31.2 casi-20210930xex31d2.htm EX-31.2 12790
4 EX-32.1 casi-20210930xex32d1.htm EX-32.1 7187
5 EX-32.2 casi-20210930xex32d2.htm EX-32.2 7242
  Complete submission text file 0001558370-21-015628.txt   7795695

Data Files

Seq Description Document Type Size
6 EX-101.SCH casi-20210930.xsd EX-101.SCH 73206
7 EX-101.CAL casi-20210930_cal.xml EX-101.CAL 57936
8 EX-101.DEF casi-20210930_def.xml EX-101.DEF 258016
9 EX-101.LAB casi-20210930_lab.xml EX-101.LAB 472542
10 EX-101.PRE casi-20210930_pre.xml EX-101.PRE 422327
11 EXTRACTED XBRL INSTANCE DOCUMENT casi-20210930x10q_htm.xml XML 1248246
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 211399446
SIC: 2836 Biological Products, (No Diagnostic Substances)